Earthing

The evidence base for Earthing's effect on sleep-quality scores 7.0/10, with a small randomized, double-blind trial reporting a modest increase in total sleep time Park 2025. Earthing interventions for sleep-quality have also been described in an early pilot that measured cortisol and subjective sleep improvements in twelve participants, but that study lacked a control group and remains low-certainty evidence Ghaly and Teplitz 2004. Overall, the data are limited to pilot-scale trials with fewer than one hundred subjects, and most secondary outcomes did not separate clearly from sham conditions. Consequently, the current tier of evidence is modest, supporting cautious optimism rather than definitive conclusions.

Brown 2010 reports a modest reduction in delayed-onset muscle soreness after grounding, but the study involved only a handful of participants and cannot support a strong athletic-performance claim. Earthing is proposed for the recovery-repair use case, aiming to lessen post-exercise inflammation and speed tissue repair. The evidence tier for this claim remains low; the pilot trial showed a small signal, and larger, well-controlled studies are lacking. A postoperative study of 84 patients found a modest pain-reduction trend with Earthing, yet the sample size fell short of the threshold for definitive conclusions. Consequently, the recovery-repair score of 6.0 / 10 reflects modest promise tempered by limited, low-certainty data.

The evidence base for Earthing's impact on HRV-vagal-tone is modest, with the only trial reporting autonomic outcomes showing no clear benefit (Park 2025). Earthing received a use-case score of 6.0/10 for the hrv-vagal-tone application, reflecting limited but intriguing signals. Earlier work by Chevalier in 2011 suggested possible shifts in heart-rate variability, yet the study lacked a matched PMID and did not isolate vagal tone measures. Subsequent small pilots, such as the sleep-focused Earthing mat study, failed to separate HRV changes from sham conditions. Overall, the tier of evidence remains low, and responders report mixed effects, so the claim remains tentative.

The anti-inflammatory rating for Earthing is 6.0 /10, based on a modest postoperative study that observed lower inflammatory markers in 84 patients (Sokal 2025). Earthing's anti-inflammatory claim rests on this single trial and a narrative review that links grounding to reduced cytokine activity (Oschman 2015). Both sources are low-tier: the trial lacks a sham control and includes fewer than 100 participants, while the review suffers from author-overlap and does not present new data. Consequently, the evidence tier is weak, and responders report modest benefits that require confirmation in larger, blinded trials.

The evidence base for Earthing in chronic-pain scores 7.0/10, with Sokal et al. 2025 reporting greater postoperative VAS pain reduction than sham. Earthing as a grounding intervention shows modest analgesic signals in early surgical contexts, but larger independent trials are still missing. Ghaly and Teplitz 2004 adds pilot-level subjective pain data, yet the study lacked a control group and involved only twelve participants. Together these findings place the evidence at a low to moderate tier, suggesting possible benefit for some individuals but insufficient proof for broad clinical recommendation. Users considering Earthing for chronic-pain should weigh the limited data against personal tolerance and cost.

A controlled grounding experiment measured a 60 Hz body voltage drop of about 30 % when participants used an Earthing mat, and recorded currents remained below perception thresholds Chamberlin 2014. The Earthing use case emf-frequency receives a score of 6.5/10 because the physical data show modest exposure reduction but no direct health outcomes. Evidence sits in tier 2, meaning it comes from laboratory-type measurements rather than large clinical trials. Responders note that lower body voltage may lessen interference with electronic medical devices, yet the magnitude of change is small. Overall, the rationale reflects a plausible biophysical effect while acknowledging that clinical relevance remains unproven.

Current evidence gives Earthing a modest 5.5/10 rating for mood, based on the short-term improvement reported in a small double-blind pilot Chevalier 2015. Earthing for the mood use case rests on a handful of early studies that measured self-reported affect after a single grounding session. The pilot showed a statistically significant rise in positive affect, but the sample size was under 30 and lacked independent replication. Subsequent larger trials have focused on sleep or pain outcomes and did not include mood as a primary endpoint, leaving the evidence tier at low-quality pilot data. Consequently, the claim that Earthing reliably boosts mood remains tentative, and further controlled studies are needed before stronger conclusions can be drawn.

The cardiovascular score for Earthing is 5.0 / 10, based on the limited data reported in Chevalier 2012. Earthing's cardiovascular use case rests on a handful of small, unblinded or narrative studies that suggest modest effects on heart-rate variability and blood viscosity, but none meet the criteria for high-quality randomized trials. No endorsement from the American Heart Association or European Society of Cardiology appears in the audit, and the existing reports fall into a low evidence tier (Tier C). Consequently, the evidence supports only tentative, exploratory interest in Earthing for cardiovascular health, matching the assigned 5.0 / 10 score.

The evidence yields a score of 5.0/10 for stress-resilience with Earthing, based on the pilot reporting cortisol and subjective stress changes in twelve participants without a sham control Ghaly and Teplitz 2004. Earthing aims to reduce physiological arousal by allowing free electron flow between the body and the planet, a mechanism that could dampen the sympathetic stress response. The Ghaly study showed modest reductions in self-rated stress and a small drop in morning cortisol, but the lack of a control group and the tiny sample keep the evidence at a low tier. No larger randomized trials have directly measured stress-resilience outcomes for Earthing, and the few related investigations focus on sleep or pain rather than stress markers. Consequently, the modest score reflects limited data, modest effect size, and minimal downside risk.